Company profile: Agritope
1.1 - Company Overview
Company description
- Provider of new fruit and vegetable plant varieties for the fresh produce industry, utilizing patented ethylene control technology to develop fruits and vegetables resistant to the decaying effects of ethylene.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Agritope
AutoGenomics
HQ: United States
Website
- Description: Provider of automated microarray-based multiplex molecular diagnostic platforms and genetic testing tools, including INFINITI System, INFINITI PLUS Analyzer, INFINITI High Throughput System, proprietary BioFilmChip microarrays, and assays such as AvertD for opioid use disorder risk and Factor II-V Leiden for thrombophilia, for disease signature assessment in women's health, cancer and personalized medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AutoGenomics company profile →
RNAissance Ag
HQ: United States
Website
- Description: Provider of ribonucleic acid and RNAi products, offering innovative technology for large-scale fermentation-based production of exogenous RNAi, addressing mass production challenges and enabling farmers to protect and improve crops and cattle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RNAissance Ag company profile →
Nutcracker Therapeutics
HQ: United States
Website
- Description: Provider of mRNA therapeutics and an integrated RNA manufacturing platform: the Nutcracker Manufacturing Unit (NMU) for rapid mRNA production from DNA sequences; GMP-in-a-box to lower costs and cycle times; CodonCracker software to optimize RNA sequences; Nutshell delivery vehicles; an RNA therapeutics pipeline across HPV-driven tumors, T cell lymphoma, and genitourinary tumors; and strategic collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutcracker Therapeutics company profile →
GenoKey
HQ: Denmark
Website
- Description: Provider of AI-driven combinatorial analytics of genomic and clinical data via the PrecisionLife Innovation Engine to discover novel drug targets, identify drug repositioning candidates, and design diagnostic, prognostic and theranostic clinical decision support tools. Offers precision biopharma and healthcare solutions, including combinatorial risk scores to predict and prevent chronic diseases such as dementia, diabetes and cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoKey company profile →
Denovo Biopharma
HQ: United States
Website
- Description: Provider of biomarker-driven personalized drug development, advancing a pipeline of therapeutics: DB107, a cancer-selective immunotherapy combining gene therapy with a prodrug conversion strategy; DB102 (enzastaurin) guided by DGM1 for DLBCL/GBM; psychiatric candidates DB104 (TRD), DB103 (mGlu2/3), DB105 for Alzheimer’s; and oncology agent DB106 (vosaroxin) for AML and solid tumors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Denovo Biopharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Agritope
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Agritope
2.2 - Growth funds investing in similar companies to Agritope
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Agritope
4.2 - Public trading comparable groups for Agritope
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →